Key regions: United Kingdom, Germany, France, South Korea, Italy
The COVID-19 vaccines market in Togo is seeing a steady growth in demand as the country continues to roll out its vaccination program.
Customer preferences: The Togolese government has been actively promoting vaccination through various campaigns and initiatives. As a result, there is a growing awareness and acceptance of the COVID-19 vaccine among the population. The majority of Togolese are willing to get vaccinated, with many seeing it as a crucial step towards ending the pandemic.
Trends in the market: The COVID-19 vaccines market in Togo is primarily dominated by the AstraZeneca vaccine, which was procured through the COVAX facility. The government has also received donations of vaccines from China and India, which have helped to increase the supply of vaccines in the country. There has been a recent uptick in demand for the Johnson & Johnson vaccine, which is a single-dose vaccine that is more convenient for those living in remote areas.
Local special circumstances: Togo is a small country with a population of around 8 million people. The country has a relatively weak healthcare system, which has been further strained by the pandemic. The government has been working to strengthen the healthcare system and increase access to healthcare services, including vaccination. However, there are still challenges in reaching remote areas and ensuring that everyone has access to the vaccine.
Underlying macroeconomic factors: Togo is one of the poorest countries in the world, with a GDP per capita of around $700. The pandemic has had a significant impact on the economy, with many businesses and individuals struggling to make ends meet. The government has been working to provide economic support to those affected by the pandemic, but there are still challenges in ensuring that everyone has access to basic necessities like food and healthcare. The vaccination program is seen as a crucial step towards ending the pandemic and restoring economic growth in the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
